Longitudinal changes of speech and voice disorders following subthalamic stimulation in Parkinson’s disease patients
Objective: To elucidate longitudinal changes of speech and voice disorders in Parkinson's disease (PD) patients treated with subthalamic nucleus deep brain stimulation (STN-DBS). Background: Previously,…A cross-linguistic approach to speech intelligibility in people with PD
Objective: The purpose is to compare acoustic models of speech intelligibility in individuals with the same disease (Parkinson's disease, PD) but with different native languages,…Speech 10 years post bilateral STN-DBS for Parkinson’s disease
Objective: This study reports on the type and severity of speech problems up to 10 years after bilateral deep brain stimulation (DBS) of the subthalamic…Dopaminergic medication effect on speech in Parkinson’s disease: A kinematic study
Objective: To investigate the effect of levodopa on articulatory movement during Cantonese plosive production in individuals with Parkinson's disease (PD) by comparing kinematic parameters before…Articulography reveals disturbed speech motor control in ET patients treated with VIM-DBS
Objective: We investigate the effect of VIM-DBS on speech production in patients with ET. Background: Dysarthria is a common side effect of VIM-DBS. In recent…Voice harmonic amplitude differences before and after LSVT LOUDTM in Parkinson’s disease
Objective: To evaluate voice harmonic amplitudes from acoustic spectra of speech produced by subjects with Parkinson's disease (PD) before and after voice treatment, in order…Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson’s patients
Objective: The current study adopted a randomized control trial (RCT) design to investigate the impact of expiratory muscle strength training (EMST) on vocal loudness and…Parkinson patient reported outcomes of voice and communication pre, post and 6 months following LSVT LOUD® and LSVT ARTIC
Objective: To evaluate the functional impact of LSVT LOUD and LSVT ARTIC on voice and communication in individuals with Parkinson's disease (PD) immediately post and…Speech evaluation in Parkinson’s disease using a transcribed version of the Frenchay dysarthria assessment
Objective: To assess the usefulness and metric properties of a transcribed version of the Frenchay Dysarthria Assessment 2 (FDA-2) for speech evaluation in a cohort…Speech and voice range profile in patients with Parkinson’s disease with deep brain stimulation: Preliminary data
Objective: To assess the use of Voice Range Profile(VRP) and Speech Range Profile(SRP) in the evaluation of patients with on and off Deep brain stimulation(DBS).…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.